ProfileGDS5678 / 1419056_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 8% 74% 72% 8% 8% 8% 8% 8% 8% 9% 8% 9% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.208228
GSM967853U87-EV human glioblastoma xenograft - Control 24.8409274
GSM967854U87-EV human glioblastoma xenograft - Control 34.6002372
GSM967855U87-EV human glioblastoma xenograft - Control 42.153848
GSM967856U87-EV human glioblastoma xenograft - Control 52.152578
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.232638
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.195128
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.180738
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.181798
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.196789
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.181298
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.181949
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.191318
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.188538